Saniona Is A Clinical Stage Biopharmaceutical Company Based In Copenhagenfocusing On Neurologicalpsychiatricand Rare Diseases Through Ion Channel Modulationfounded In 2011 By Neurobiologist Ja Rgen Drejerthe Company Utilizes Over 20 Years Of Research To Develop Innovative Therapies For Conditions With Significant Unmet Medical Needssuch As Epilepsy And Rare Eating Disorders The Company Operates A Proprietary Drug Discovery Engine With A Library Of Over 20 000 Ion Channel Modulatorssaniona S Product Pipeline Includes Tesomettargeting Prader Willi Syndrome And Hypothalamic Obesityand San711Which Is In Development For Rare Neuropathic Pain And Absence Seizuresother Candidates Address Various Conditionsincluding Inflammatory Disorders And Major Depressive Disordersaniona Collaborates With Several Partnersincluding Acadia Pharmaceuticals And Productos Medixto Advance Its Therapeutic Offerings And Expand Its Market Reach
